Clinical Trial Update: Evaluation of MST-188 in Acute Lower Limb Ischemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MST-188 for acute limb ischemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Ischemia

Drugs mentioned

• MST-188 (MST-188)

Snippet

Sponsor: Mast Therapeutics, Inc. | Conditions: Acute Limb Ischemia | Phase 2 | Status: TERMINATED